Ofer Sharon, MD is the CEO of OncoHost Ltd. a clinical stage precision oncology company combining blood based proteomic analysis and powerful machine learning tools in order to predict response to immunotherapy and provide clinicians with potential combinations strategies to overcome treatment resistance and improve patient outcomes.
Dr. Sharon is a physician and entrepreneur with close to 20 years of experience in clinical and commercial product development for startups in the health tech, biotech, and medical device industries. Ofer is the co-founder and President of Valera Health a commercial stage US-Israeli startup company developing a digital platform for payers and providers for severe mental illness serving more than 4 million patients in the US. Prior to joining Oncohost, he served multiple roles in global pharmaceutical companies including Medical Director for AstraZeneca (Israel), new technologies scout for Medimmune and Medical Director for MSD (Israel). He co-founded several healthcare companies, mainly focusing on bioinformatic and machine learning platforms for clinical deterioration detection and early intervention.